Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Society for Immunotherapy of Cancer revenue
Society for Immunotherapy of Cancer's revenue is $5.0 million.
What is Society for Immunotherapy of Cancer's revenue?
- Society for Immunotherapy of Cancer has 46 employees, and the revenue per employee ratio is $108,696.
- Society for Immunotherapy of Cancer peak revenue was $5.0M in 2024.
On this page
Zippi applies for you, and finds you a job.
Society for Immunotherapy of Cancer competitors
Society for Immunotherapy of Cancer's top competitor, Agenus, earned an annual revenue of $103.0M.
Society for Immunotherapy of Cancer's smallest competitor is Genetics Society of America with revenue of $4.0M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| American Gastroenterological Association | - | $21.0M | 144 | - |
| Infectious Diseases Society of America | - | $50.0M | 20 | - |
| Genetics Society of America | - | $4.0M | 55 | - |
| Agenus | - | $103.0M | 294 | - |
| AnaptysBio | - | $91.3M | 78 | - |
| Society for Neuroscience | - | $32.0M | 50 | - |
| American Society of Hematology | - | $68.0M | 179 | - |
| CoreNet Global | - | $13.7M | 20 | - |
| Institute of Real Estate Management | - | $12.2M | 2,017 | - |
| Austin Board Of Realtors® | - | $5.0M | 6 | - |
Society for Immunotherapy of Cancer revenue FAQs
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Society for Immunotherapy of Cancer, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Society for Immunotherapy of Cancer. The employee data is based on information from people who have self-reported their past or current employments at Society for Immunotherapy of Cancer. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Society for Immunotherapy of Cancer. The data presented on this page does not represent the view of Society for Immunotherapy of Cancer and its employees or that of Zippia.
Society for Immunotherapy of Cancer may also be known as or be related to SOCIETY FOR IMMUNOTHERAPY OF, Society For Immunotherapy Of Cancer (sitc), Society for Immunotherapy of Cancer and Society for Immunotherapy of Cancer (SITC).